Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway

Journal of Pineal Research

Volumn 50, Issue 4, 2011, Pages 403-411

  Kang, Jung Woo ^a   Koh, Eun Ji ^a   Lee, Sun Mee ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

HMGB1; inflammation; ischemia reperfusion; melatonin; toll like receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; BETA INTERFERON; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 6; MELATONIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; BLOOD SAMPLING; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; IMMUNOMODULATION; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEME OXYGENASE-1; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MALE; MELATONIN; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954419206     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00858.x     Document Type: Article

References (45)

1. Fondevila C, Busuttil RW, Kupiec-Weglinski JW,. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 2003; 74: 86-93. (Pubitemid 36438656)
2. Skopp G, Schmitt HP, Pedal I,. Fulminant liver failure in a patient on carbamazepine and levetiracetam treatment associated with status epilepticus. Arch Kriminol 2006; 217: 161-175. (Pubitemid 44030723)
3. Teoh NC, Farrell GC,. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902. (Pubitemid 37056167)
4. O'neill LA,. Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol 2003; 3: 396-403. (Pubitemid 36913535)
5. Tsung A, Sahai R, Tanaka H, et al., The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005; 201: 1135-1143. (Pubitemid 40524681)
6. Hertzog PJ, O'neill LA, Hamilton JA,. The interferon in TLR signaling: more than just antiviral. Trends Immunol 2003; 24: 534-539. (Pubitemid 37205204)
7. Cavassani KA, Ishii M, Wen H, et al., TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008; 205: 2609-2621.
8. Xiao X, Zhao P, Rodriguez-Pinto D, et al., Inflammatory regulation by TLR3 in acute hepatitis. J Immunol 2009; 183: 3712-3719.
9. Tan DX, Chen LD, Poeggler B, Manchester LC, Reiter RJ,. Melatonin; a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
10. Gitto E, Pellegrino S, Gitto P, et al., Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009; 46: 128-139.
11. Hardeland R, Tan DX, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
12. Rodriguez C, Mayo JC, Sainz RM, et al., Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9. (Pubitemid 38130283)
13. Zhang WH, Li JY, Zhou Y,. Melatonin abates liver ischemia/reperfusion injury by improving the balance between nitric oxide and endothelin. Hepatobiliary Pancreat Dis Int 2006; 5: 574-579. (Pubitemid 44782099)
14. Liang R, Nickkholgh A, Hoffmann K, et al., Melatonin protects from hepatic reperfusion injury through inhibition of IKK and JNK pathways and modification of cell proliferation. J Pineal Res 2009; 46: 8-14.
15. Kim SH, Lee SM,. Cytoprotective effects of melatonin against necrosis and apoptosis induced by ischemia/reperfusion injury in rat liver. J Pineal Res 2008; 44: 165-171.
16. Fukata M, Vamadevan AS, Abreu MT,. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin Immunol 2009; 21: 242-253.
17. Tsung A, Hoffman RA, Izuishi K, et al., Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005; 175: 7661-7668. (Pubitemid 41713466)
18. Yao XM, Chen H, Li Y,. Protective effect of bicyclol on liver injury induced by hepatic warm ischemia/reperfusion in rats. Hepatol Res 2009; 39: 833-842.
19. Jin X, Wang L, Wu HS, et al., N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2007; 6: 284-289. (Pubitemid 46925250)
20. Uchida Y, Freitas MC, Zhao D, et al., The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury. Transplantation 2010; 89: 1050-1056.
21. Pei Z, Cheung RT,. Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model. J Pineal Res 2004; 37: 85-91. (Pubitemid 39120211)
22. Tai SH, Chen HY, Lee EJ, et al., Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. J Pineal Res 2010; 49: 332-341.
23. Yurtcu M, Abasiyanik A, Avunduk MC, et al., Effects of melatonin on spermatogenesis and testicular ischemia-reperfusion injury after unilateral testicular torsion-detorsion. J Pediatr Surg 2008; 43: 1873-1878.
24. Cho EH, Koh PO,. Proteomic identification of proteins differentially expressed by melatonin in hepatic ischemia-reperfusion injury. J Pineal Res 2010; 49: 349-355.
25. Da Silveira Cruz-Machado S, Carvalho-Sousa CE, Tamura EK, et al., TLR4 and CD14 receptors expressed in rat pineal gland trigger NFKB pathway. J Pineal Res 2010; 49: 183-192.
26. Patole PS, Grone HJ, Segerer S, et al., Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 2005; 16: 1326-1338. (Pubitemid 41716517)
27. Brentano F, Schorr O, Gay RE, et al., RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 2005; 52: 2656-2665. (Pubitemid 41369093)
28. Zhou R, Wei H, Sun R, et al., Recognition of double-stranded RNA by TLR3 induces severe small intestinal injury in mice. J Immunol 2007; 178: 4548-4556. (Pubitemid 46492407)
29. Huang SH, Cao XJ, Wei W,. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages. J Pineal Res 2008; 45: 93-100. (Pubitemid 351986267)
30. Tian J, Avalos AM, Mao SY, et al., Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8: 487-496. (Pubitemid 46605917)
31. Park JS, Svetkauskaite D, He Q, et al., Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7377. (Pubitemid 38294612)
32. Yang H, Hreggvidsdottir HS, Palmblad K, et al., A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A 2010; 107: 11942-11947.
33. Takeda K, Kaisho T, Akira S,. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376. (Pubitemid 37174535)
34. Kaizu T, Ikeda A, Nakao A, et al., Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am J Physiol 2008; 294: G236-G244.
35. Bradham CA, Stachlewitz RF, Gao W, et al., Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 1997; 25: 1128-1135. (Pubitemid 27199939)
36. Uehara T, Xi Peng X, Bennett B, et al., c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation 2004; 78: 324-332. (Pubitemid 39095396)
37. Takahashi Y, Ganster RW, Gambotto A, et al., Role of NF-kappaB on liver cold ischemia-reperfusion injury. Am J Physiol 2002; 283: G1175-G1184. (Pubitemid 35192855)
38. Sato S, Sugiyama M, Yamamoto M, et al., Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 2003; 171: 4304-4310. (Pubitemid 37238709)
39. Fitzgerald KA, Mcwhirter SM, Faia KL, et al., IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4: 491-496. (Pubitemid 36592443)
40. Zhai Y, Shen XD, O'connell R, et al., Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 7115-7119. (Pubitemid 39628144)
41. Chen CC, Chow MP, Huang WC, et al., Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships. Mol Pharmacol 2004; 66: 683-693.
42. Lee JK, Kim SY, Kim YS, et al., Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochem Pharmacol 2009; 77: 1391-1400.
43. Shen XD, Ke B, Zhai Y, et al., Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003; 37: 296-303. (Pubitemid 36152528)
44. Shen XD, Ke B, Zhai Y, et al., Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 2005; 5: 1793-1800. (Pubitemid 41039851)
45. Tsuchihashi S, Zhai Y, Bo Q, et al., Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling. Transplantation 2007; 83: 1628-1634. (Pubitemid 46987916)